The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
646 jobs Number of planned job losses
134 jobs Number of planned job creations
Announcement Date
11 March 2020
Employment effect (start)
1 May 2020
Foreseen end date
Description
Laboratoires Boiron, the world leader in homeopathic medicines, announced a reorganisation plan with 646 job cuts. The group is facing a sharp decline in sales and profitability since the French government's decision to stop reimbursement of this alternative medication by the social security system. The group has decided to close one of its three production sites, at Montrichard near Tours (69 jobs), and 12 of the 27 preparation-distribution sites in France. The reorganisation plan also provides for the creation of 134 new positions.
Laboratoires Boiron employs 3,200 people, including 2,500 in France. Production is 100% French. And its French turnover (56% of its 2019 income) is 70% dependent on medicines that were reimbursable.
Eurofound (2020), Laboratoires Boiron, Internal restructuring in France, factsheet number 100003, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/100003.